Transesophageal Echocardiography in Embolic Stroke of Undetermined Source (ETO)
Therapeutic Implications of Early Transesophageal Echocardiography in Embolic Stroke of Undetermined Source (ESUS)
Sponsor: Fondation Ophtalmologique Adolphe de Rothschild
This observational or N/A phase trial investigates Embolic Stroke of Undetermined Source and Ischemic Stroke and is currently completed. Fondation Ophtalmologique Adolphe de Rothschild leads this study, which shows 10 recorded versions since 2016 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Sep 2021 — Jul 2024 [monthly]
Completed
-
Jan 2021 — Sep 2021 [monthly]
Completed
-
Mar 2019 — Jan 2021 [monthly]
Completed
Status: Active Not Recruiting → Completed
▶ Show 5 earlier versions
-
Nov 2018 — Mar 2019 [monthly]
Active Not Recruiting
-
Aug 2018 — Nov 2018 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Jun 2018 — Aug 2018 [monthly]
Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
May 2017 — Apr 2018 [monthly]
Recruiting NA
First recorded
Oct 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Fondation Ophtalmologique Adolphe de Rothschild
For direct contact, visit the study record on ClinicalTrials.gov .